AVEO : Summary for AVEO Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets open in 8 mins.

AVEO Pharmaceuticals, Inc. (AVEO)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.65-0.02 (-3.43%)
At close: 4:00PM EDT

0.52 -0.13 (-19.47%)
Pre-Market: 9:21AM EDT

People also watch
PBMDANTHARQLINFISNTA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.67
Open0.00
Bid0.51 x 3700
Ask0.59 x 400
Day's Range0.64 - 0.68
52 Week Range0.54 - 1.15
Volume196,845
Avg. Volume325,221
Market Cap71.94M
Beta1.82
PE Ratio (TTM)-1.48
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire13 minutes ago

    AVEO Announces Pricing of $15.0 Million Public Offering of Common Stock

    AVEO Pharmaceuticals, Inc. today announced that it has priced an underwritten public offering of 30,000,000 shares of common stock at a price to the public of $0.50 per share, before underwriting discounts, which would result in aggregate gross proceeds of approximately $15 million.

  • Business Wire3 hours ago

    AVEO Announces Proposed Offering of Common Stock

    AVEO Pharmaceuticals, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

  • AVEO (AVEO) Reports Narrower-than-Expected Loss in Q4
    Zacks5 days ago

    AVEO (AVEO) Reports Narrower-than-Expected Loss in Q4

    AVEO Pharmaceuticals, Inc. (AVEO) reported a narrower-than-expected loss in the fourth-quarter 2016.